<
>
Pralatrexate (146464-95-1)
Product Summary
Pralatrexate (52853-40-4) is a DHFR inhibitor for PTCL treatment. Available in CP/EP specs, 98% assay, 2-year shelf life. Custom specifications and bulk packaging (25kg/drum) available.
Product Custom Attributes
CAS:
52853-40-4
Specification:
CP, EP, In-house, As Required
M.F.:
C23H23N7O5
M.W.:
477.47
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Pralatrexate 52853-40-4
,anti tumor pralatrexate t cell lymphoma
,CAS: 52853-40-4 pralatrexate t cell lymphoma
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS: 52853-40-4; anti-tumor ; pralatrexate t cell lymphoma
Payment Terms:
L/C,T/T
Product Description
Pralatrexate (52853-40-4)
Pralatrexate is an injectable DHFR inhibitor approved for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This antineoplastic agent works by inhibiting folate enzymes DHFR and thymidylate synthase, representing a well-validated approach to cancer treatment.
Product Specifications
| Product Name: | Pralatrexate |
| CAS No.: | 52853-40-4 |
| Assay: | 98.9% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C23H23N7O5 |
| Molecular Weight: | 477.47 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Product Documentation
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
